The implication of these conservative valuations is that the upside - if it comes - can be be big and sudden. Asked if he held any ‘unicorns’ or unlisted companies worth a $1 billion, Woodford cited Purplebricks and two other of the trust’s top unquoted holdings, Benevolent AI, Immunocore. ‘These unicorns will become elephants soon,’ he predicted. Investors will hope Woodford is right. If not, the danger is the number of investors abandoning Patient Capital could become a stampede, further depressing its shares.
News 
Market Data 
Discover 
